Edition:
United Kingdom

Pacira Pharmaceuticals Inc (PCRX.OQ)

PCRX.OQ on NASDAQ Stock Exchange Global Select Market

43.85USD
15 Dec 2017
Change (% chg)

$-0.85 (-1.90%)
Prev Close
$44.70
Open
$44.85
Day's High
$45.25
Day's Low
$43.60
Volume
610,022
Avg. Vol
176,652
52-wk High
$58.80
52-wk Low
$29.90

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 70.93 -0.492
Mar '17 69.28 -0.523
FY 2016 Dec '16 72.90 -0.106
Sep '16 68.36 -0.594
Jun '16 69.64 -0.214
Mar '16 65.47 -0.104
FY 2015 Dec '15 69.32 -0.068
Sep '15 62.21 0.080
Jun '15 59.15 0.000
Mar '15 58.32 0.030
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 16 79.38 86.00 75.21 87.38
Quarter Ending Mar-18 6 74.31 76.18 71.30 87.50
Year Ending Dec-17 16 287.00 300.00 281.19 315.16
Year Ending Dec-18 16 334.46 415.60 310.40 399.56
Earnings (per share)
Quarter Ending Dec-17 14 0.11 0.27 -0.02 0.44
Quarter Ending Mar-18 5 0.02 0.23 -0.14 0.47
Year Ending Dec-17 13 -0.12 0.09 -0.27 0.99
Year Ending Dec-18 15 0.78 1.60 -0.06 2.26
LT Growth Rate (%) 1 10.40 10.40 10.40 68.17
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 32.93
P/E High - Last 5 Yrs. 1,708.72 40.91 45.62
P/E Low - Last 5 Yrs. 1,708.72 23.80 24.34
Beta 2.08 0.90 0.88
Price to Sales (TTM) 5.24 3.93 5.40
Price to Book (MRQ) 5.65 4.81 5.38
Price to Tangible Book (MRQ) 7.02 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions -- 0.88 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) -- 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1.86 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago 5.56 4.66 5.38
Sales - 5 Yr. Growth Rate 77.49 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -129.69 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago -460.21 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate 31.99 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 7.26 2.11 2.18
Current Ratio (MRQ) 7.84 2.88 2.98
LT Debt to Equity (MRQ) 103.17 9.47 11.56
Total Debt to Equity (MRQ) 103.29 13.43 15.81
Interest Coverage (TTM) -0.68 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 59.09 55.14 54.83
Gross Margin - 5 Yr. Avg. 59.15 52.29 52.40
EBITD Margin (TTM) -12.56 -- --
EBITD - 5 Yr. Avg -9.95 18.46 15.24
Operating Margin (TTM) -20.21 14.50 7.76
Operating Margin - 5 Yr. Avg. -15.91 14.42 10.75
Pre-Tax Margin (TTM) -23.33 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -19.57 14.74 11.17
Net Profit Margin (TTM) -23.36 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -19.58 11.08 7.47
Effective Tax Rate (TTM) -- 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 559,590 953,213,828 864,680,848
Net Income/Employee (TTM) -130,706 112,151,383 101,718,394
Receivable Turnover (TTM) 10.03 5.60 5.76
Inventory Turnover (TTM) 2.44 2.58 3.34
Asset Turnover (TTM) 0.56 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -13.06 11.42 11.00
Return on Assets - 5 Yr. Avg. -13.30 13.00 12.43
Return on Investment (TTM) -16.47 14.86 14.46
Return on Investment - 5 Yr. Avg. -21.18 17.00 16.28
Return on Equity (TTM) -26.87 16.28 16.05
Return on Equity - 5 Yr. Avg. -26.34 18.03 17.51
  1 Year 3 Year 5 Year
Sales % 10.99 47.83 77.49
EPS (TTM) % -2,367.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pacira Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.48 -4.88 31 25
13 Week -27.48 -31.01 8 37
26 Week -20.80 -26.82 21 30
52 Week 5.15 -10.88 55 12
YTD 13.16 -0.62 64 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 271
Total Shares Held: 45,588,034
3 Mo. Net Change: 2,727,816
# New Positions: 35
# Closed Positions: 42
# Increased Positions: 128
# Reduced Positions: 103
# Net Buyers: 25
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.